thought leadership

BioPharm Intl Regulatory Sourcebook: GMPs Guide COVID-19 Vaccine Manufacturing

Excerpt taken from BioPharm International October 2020 Regulatory Sourcebook article titled: GMPs Guide COVID-19 Vaccine Manufacturing.

“The FDA Guidance highlights the pertinent CGMP [current good manufacturing practice] considerations for all vaccine manufacturing and serves as a reminder of statutory GMP expectations for COVID-19 vaccines specifically,” says Karolyn Gale, senior director, regulatory affairs, Emergent BioSolutions."

View the full article here.


BioPharm InternationalBioPharm International-10-15-2020, Volume 2020 eBook, Issue 3
Page Number: 56-59

Strategizing for Rapid Changeovers in Biologics Manufacturing

Syed T. Husain, senior vice president and CDMO business unit head at Emergent BioSolutions recently contributed to an editorial...


Editorial: Good Manufacturing Practices: Challenges with Compliance

Dino Muzzin, Senior Vice President, Manufacturing Operations at Emergent, recently contributed to an article in BioPharm...


May 4th Webinar: Rapid Readiness for Pandemic Response

Watch our latest webinar on the topic of how drug developers can maximize capacity, capabilities and expertise for pandemic...